E1	Condition:T1 Name:T2 Temporality:E25
E3	Condition:T3 Name:T4
E5	Condition:T5 Name:T6
E7	Condition:T7 Name:T8 Temporality:E27
E9	Procedure:T9 Name:T10
E13	Condition:T13 Name:T14 Temporality:E26
E15	Procedure:T15 Name:T16 Temporality:E16
E16	Eq-Comparison:T25 Operator:T17 Temporal-Unit:T19 Value:T24
E17	Eq-Comparison:T26 Value:T22 Value2:T23 Value3:T23 Operator:T33
E2	Condition:T28 Name:T29
E4	Eq-Comparison:T30 Operator:T31 Value:T21 Temporal-Unit:T18
E8	Age:T34 Numeric-Filter:E17
E10	Study:T35
E12	Contraindication:T36 Contraindicates:E9
E14	Drug:T37 Name:T38
E18	Condition:T39 Name:T40
E19	Observation:T41 Name:T42
E20	Condition:T43 Name:T44 Temporality:E28
E21	Study:T12
E22	Procedure:T45 Name:T46
E23	Negation:T47 Negates:E22
E24	Study:T48
E25	Eq-Comparison:T49 Temporal-Recency:T27
E26	Eq-Comparison:T50 Temporal-Period:T51
E27	Eq-Comparison:T52 Temporal-Period:T53
E28	Eq-Comparison:T54 Temporal-Period:T55
E29	Other:T56 Is-Other:E20
E30	Other:T57 Is-Other:E22
T1	Condition 36 42	stroke
T2	Condition-Name 36 42	stroke
T3	Condition 84 90	stroke
T4	Condition-Name 84 90	stroke
T5	Condition 121 127	stroke
T6	Condition-Name 121 127	stroke
T7	Condition 350 373	cardiovascular diseases
T8	Condition-Name 350 373	cardiovascular diseases
T9	Procedure 253 265	dry needling
T10	Procedure-Name 253 265	dry needling
T13	Condition 328 336	diabetes
T14	Condition-Name 328 336	diabetes
T15	Procedure 440 445	Botox
T16	Procedure-Name 440 445	Botox
T17	Eq-Operator 446 452	within
T18	Eq-Temporal-Unit 108 114	months
T19	Eq-Temporal-Unit 455 461	months
T20	Eq-Operator 168 169	-
T21	Eq-Value 106 107	6
T22	Eq-Value 166 168	18
T23	Eq-Value 169 171	75
T24	Eq-Value 453 454	6
T25	Eq-Comparison 446 461	within 6 months
T26	Eq-Comparison 146 171	between the ages of 18-75
T27	Eq-Temporal-Recency 25 35	First time
T28	Condition 66 76	spasticity
T29	Condition-Name 66 76	spasticity
T30	Eq-Comparison 97 114	At least 6 months
T31	Eq-Operator 97 105	At least
T33	Eq-Operator 146 153	between
T34	Age 158 162	ages
T35	Study 196 201	study
T36	Contraindication 232 248	contraindication
T37	Drug 271 285	anticoagulants
T38	Drug-Name 271 285	anticoagulants
T39	Condition 287 297	infections
T40	Condition-Name 287 297	infections
T41	Observation 299 307	bleeding
T42	Observation-Name 299 307	bleeding
T43	Condition 397 418	neurological problems
T44	Condition-Name 397 418	neurological problems
T12	Study 475 480	study
T45	Procedure 519 536	treatment program
T46	Procedure-Name 519 536	treatment program
T47	Negation 542 545	not
T48	Study 565 570	study
T49	Eq-Comparison 25 35	First time
T50	Eq-Comparison 321 327	Having
T51	Eq-Temporal-Period 321 327	Having
T52	Eq-Comparison 343 349	Having
T53	Eq-Temporal-Period 343 349	Having
T54	Eq-Comparison 380 386	Having
T55	Eq-Temporal-Period 380 386	Having
T56	Other 391 396	other
T57	Other 511 518	another
A1	Eq-Operator-Value T17 LTEQ
A2	Eq-Temporal-Unit-Value T18 month
A3	Eq-Temporal-Unit-Value T19 month
A4	Eq-Operator-Value T20 BETWEEN
A5	Eq-Temporal-Recency-Value T27 first-time
A6	Eq-Operator-Value T31 GTEQ
A9	Eq-Temporal-Period-Value T51 present
A10	Eq-Temporal-Period-Value T53 present
A11	Eq-Temporal-Period-Value T55 present
A12	Eq-Operator-Value T33 BETWEEN
R1	Caused-By Arg1:E2 Arg2:E3
R2	Example-Of Arg1:E14 Arg2:E12
R3	Example-Of Arg1:E18 Arg2:E12
R4	Example-Of Arg1:E19 Arg2:E12
R5	After Arg1:E4 Arg2:E5
R6	Before Arg1:E16 Arg2:E21
R7	Or Arg1:E14 Arg2:E18
R8	Or Arg1:E18 Arg2:E19